INS and diabetes mellitus: In addition, by summarizing recent findings regarding the application of the state-of-the-art CRISPR/Cas9 technology in diabetes, this review emphasis a huge potential of targeted epigenome editing in changing the differentiation state of different cell types into insulin-producing cells with ability to attenuate diabetes.